Screener
Aktis Oncology, Inc.
AKTSAktis Oncology, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew Roden, with a market cap of $910.5M.
$910.49M-16.7%
We’re still putting together Aktis Oncology, Inc.’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move Aktis Oncology, Inc. up the queue, and we’ll analyze its filings next.
Earnings
Q1 2027 report
November 12, 2026Next report
Date not yet announcedProfile
CountryUnited States of America
Listed2026
Employees79.0
CEOMatthew Roden
SectorHealthcare
IndustryBiotechnology
Websiteaktisoncology.com
FilingsSEC EDGAR